S. De-sanjose, W. G. Quint, L. Alemany, D. T. Geraets, J. E. Klaustermeier et al., Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study, Lancet Oncol, vol.11, issue.11, pp.1048-56, 2010.

I. Lombard, A. Vincent-salomon, P. Validire, B. Zafrani, A. De-la-rochefordiere et al., Human papillomavirus genotype as a major determinant of the course of cervical cancer, J Clin Oncol, vol.16, issue.8, pp.2613-2622, 1998.

B. M. Ronnett, Endocervical adenocarcinoma: selected diagnostic challenges, Mod Pathol, vol.29, issue.1, pp.12-28, 2016.

K. A. Ashton, J. Scurry, S. N. Tabrizi, S. M. Garland, G. Otton et al., The problem of late ovarian metastases from primary cervical adenocarcinoma, Gynecol Oncol Rep, vol.13, pp.23-28, 2015.

M. Peter, N. Stransky, J. Couturier, P. Hupe, E. Barillot et al., Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma, J Pathol, vol.221, issue.3, pp.320-350, 2010.

A. Holmes, S. Lameiras, E. Jeannot, Y. Marie, L. Castera et al., Mechanistic signatures of HPV insertions in cervical carcinomas, NPJ Genom Med, vol.1, p.16004, 2016.

F. Luft, R. Klaes, M. Nees, M. Durst, V. Heilmann et al., Detection of integrated papillomavirus sequences by ligationmediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells, Int J Cancer, vol.92, issue.1, pp.9-17, 2001.

R. Vang, A. M. Gown, M. Farinola, T. S. Barry, D. T. Wheeler et al., p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas, Am J Surg Pathol, vol.31, issue.5, pp.653-63, 2007.

M. Shimada, J. Kigawa, R. Nishimura, S. Yamaguchi, K. Kuzuya et al., Ovarian metastasis in carcinoma of the uterine cervix, Gynecol Oncol, vol.101, issue.2, pp.234-241, 2006.

G. Turashvili, P. Farmer, T. Colgan, and T. Childs, Human papillomavirus-related ovarian metastasis with Endocervical adenocarcinoma: report of 2 cases and review of literature, J Low Genit Tract Dis, vol.19, issue.4, pp.60-63, 2015.

M. C. Chang, N. S. Nevadunsky, A. N. Viswanathan, C. P. Crum, and C. M. Feltmate, Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival, Int J Gynecol Pathol, vol.29, issue.1, pp.88-92, 2010.

G. D. Zielinski, P. J. Snijders, L. Rozendaal, N. F. Daalmeijer, E. K. Risse et al., The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix, J Pathol, vol.201, issue.4, pp.535-578, 2003.

M. Ishikawa, T. Fujii, M. Saito, I. Nindl, A. Ono et al., Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia, Int J Gynecol Cancer, vol.16, issue.1, pp.347-53, 2006.

N. Yoon, G. Yoon, C. K. Park, and H. S. Kim, Stromal p16 expression is significantly increased in malignant ovarian neoplasms, Oncotarget, vol.7, issue.40, pp.64665-73, 2016.

R. A. Reichert, Synchronous and metachronous endocervical and ovarian neoplasms: a different interpretation of HPV data, Am J Surg Pathol, vol.29, issue.12, pp.1686-1693, 2005.

K. Hellner and K. Munger, Human papillomaviruses as therapeutic targets in human cancer, J Clin Oncol, vol.29, issue.13, pp.1785-94, 2011.